Merline Saintil - 24 Jun 2025 Form 4 Insider Report for Rocket Lab Corp (RKLB)

Role
Director
Signature
/s/ Arjun Kampani as Attorney-in-Fact for Merline Saintil
Issuer symbol
RKLB
Transactions as of
24 Jun 2025
Net transactions value
-$212,051
Form type
4
Filing time
25 Jun 2025, 16:05:05 UTC
Previous filing
23 Jun 2025
Next filing
03 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saintil Merline Director C/O ROCKET LAB CORPORATION, 3881 MCGOWEN STREET, LONG BEACH /s/ Arjun Kampani as Attorney-in-Fact for Merline Saintil 25 Jun 2025 0001699497

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RKLB Common Stock Sale $134,346 -4,053 -0.95% $33.15 421,869 24 Jun 2025 Direct F1, F2
transaction RKLB Common Stock Sale $77,705 -2,300 -0.55% $33.78 419,569 24 Jun 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2025.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.5100 to $33.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.5100 to $34.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.